Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ADHD
ADHD
Some ADHD medicines may increase psychosis more than others, ‘real-world’ data show
Stat
Wed, 03/20/19 - 08:09 pm
ADHD
psychosis
Adderall
Vyvanse
Ritalin
Concerta
Teva and Neos settle over Cotempla patent dispute
Pharmaforum
Thu, 12/27/18 - 10:17 pm
Teva Pharmaceutical
Neos Therapeutics
generics
patents
ADHD
Cotempla XR-ODT
As with children studies, Supernus ADHD drug shows fast onset of action in adolescents
Endpoints
Thu, 12/20/18 - 10:10 am
Supernus Pharmaceuticals
ADHD
clinical trials
SPN-812
Supernus says ADHD drug trounces rivals, but shares slide
Pharmaforum
Fri, 12/7/18 - 10:48 am
Supernus
ADHD
SPN-812
clinical trials
Sunovion Receives Bad News From the FDA About ADHD Drug
CP Wire
Fri, 08/31/18 - 10:45 am
Sunovion
CRL
NDA
dasotraline
ADHD
FDA
complete response letter
Sunovion Receives Bad News From the FDA About ADHD Drug
Fri, 08/31/18 - 10:42 am
Sunovion
complete response letter
dasotraline
ADHD
Ironshore Pharmaceuticals Closes on $143 Million of Financing to Launch ADHD Drug
CP WIre
Thu, 08/23/18 - 09:53 am
Ironshore Pharmaceuticals
Jornay PM
ADHD
Ironshore Pharmaceuticals Closes on $143 Million of Financing to Launch ADHD Drug
Thu, 08/23/18 - 09:47 am
Ironshore Pharmaceuticals
Jornay PM
ADHD
Shire, Shionogi File NDA for Intuniv for Adults in Japan
Yahoo/Zacks.com
Mon, 08/13/18 - 05:52 pm
Shire
Shionogi
ADHD
Japan
Intuniv
KemPharm shoots for ADHD filling in 2019
Biopharma Dive
Mon, 07/9/18 - 07:02 pm
KemPharm
ADHD
KP415
clinical trials
What is a digital medicine, exactly? Akili co-founder Adam Gazzaley explains
Medical Marketing and Media
Thu, 03/15/18 - 09:52 am
digital medicine
Akili Interactive
video games
ADHD
Shire creates separate neurosciences division for future investments; Agenus gains $28M in royalty deal
Endpoints
Mon, 01/8/18 - 11:26 am
Shire
ADHD
Neurosciences
ADHD Meds During Pregnancy Appear To Have Low Risk Of Birth Defects
Forbes
Wed, 12/13/17 - 06:31 pm
ADHD
pregnancy
birth defects
Shire announces availability of MYDAYIS(TM) for ADHD treatment in the U.S.
Seeking Alpha
Mon, 08/28/17 - 10:00 am
Shire
Mydayis
ADHD
Shire hints at ADHD spinoff, but could someone step in and buy the neuro franchise?
Fierce Pharma
Thu, 08/3/17 - 06:39 pm
Shire
ADHD
spinoffs
Shire plots an ADHD public spinoff as CEO Ornskov completes a top-to-bottom overhaul
Endpoints
Thu, 08/3/17 - 11:01 am
Shire
ADHD
Flemming Ornskov
spinoffs
Mydayis
Biotech Movers: Impax Shares Jump on FDA Approval for Generic Version of Concerta
TheStreet.com
Mon, 07/17/17 - 10:06 am
biotech
Impax Labs
FDA
generics
Concerta
ADHD
A decade behind schedule, Shire finally gets an FDA OK for long-acting ADHD drug
Endpoints
Wed, 06/21/17 - 09:50 am
Shire
FDA
ADHD
Mydayis
SHP465
Neos Therapeutics’ Controlled-Release ADHD Drug Get FDA Approval
Xconomy
Tue, 06/20/17 - 08:57 am
Neos Therapeutics
ADHD
FDA
Cotempla XR-ODT
Lilly's Strattera faces first wave of generic competition
BioPharma Dive
Fri, 06/2/17 - 11:31 am
Eli Lilly
Strattera
generics
ADHD
Apotex
Aurobindo
Glenmark
Teva Pharmaceutical
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »